Dr. Joshua D. Lee is an associate professor in the Departments of Population Health and Medicine at the NYU Grossman School of Medicine and director of the NYU Fellowship in Addiction Medicine. Dr. Lee is a clinician-researcher focused on investigating addiction pharmacotherapies in primary care and criminal justice system-involved populations. He has conducted multiple NIH clinical trials examining the use of naltrexone and buprenorphine opioid and alcohol treatments in criminal justice system-involved adults, at community re-entry, and within primary care settings.

Allison Sugarman is a Lee Lab project manager who aids in the management of all research projects. Allison has worked on and managed our multisite NIH funded grant evaluating the effectiveness of extended-release buprenorphine and extended-release naltrexone for the treatment of opioid use disorder among people released from New York City jails. Allison graduated from the University of Maryland with a bachelor’s degree in psychology and a master’s degree in public policy with a specialization in mental health.

James Swift is a participant tracker for the Lee Lab and currently works on a study evaluating the feasibility and efficacy of extended-release buprenorphine versus daily sublingual buprenorphine for the treatment of opioid use disorder among people released from NYC jails. James works in the community to locate participants, facilitate contact with the research team,  and coordinate study care.